322 related articles for article (PubMed ID: 36651193)
1. Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review.
Nelson SM; Davis SR; Kalantaridou S; Lumsden MA; Panay N; Anderson RA
Hum Reprod Update; 2023 May; 29(3):327-346. PubMed ID: 36651193
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review.
Anderson RA; Cameron D; Clatot F; Demeestere I; Lambertini M; Nelson SM; Peccatori F
Hum Reprod Update; 2022 May; 28(3):417-434. PubMed ID: 35199161
[TBL] [Abstract][Full Text] [Related]
3. Anti-Müllerian Hormone in the Diagnosis and Prediction of Premature Ovarian Insufficiency.
Anderson RA; Nelson SM
Semin Reprod Med; 2020 Sep; 38(4-05):263-269. PubMed ID: 33429444
[TBL] [Abstract][Full Text] [Related]
4. The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.
Anderson RA; Mansi J; Coleman RE; Adamson DJA; Leonard RCF
Eur J Cancer; 2017 Dec; 87():58-64. PubMed ID: 29117576
[TBL] [Abstract][Full Text] [Related]
5. Association study of anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms with idiopathic primary ovarian insufficiency.
Yoon SH; Choi YM; Hong MA; Kim JJ; Lee GH; Hwang KR; Moon SY
Hum Reprod; 2013 Dec; 28(12):3301-5. PubMed ID: 24146295
[TBL] [Abstract][Full Text] [Related]
6. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.
Visser JA; Schipper I; Laven JS; Themmen AP
Nat Rev Endocrinol; 2012 Jan; 8(6):331-41. PubMed ID: 22231848
[TBL] [Abstract][Full Text] [Related]
9. AMH mutations with reduced in vitro bioactivity are related to premature ovarian insufficiency.
Alvaro Mercadal B; Imbert R; Demeestere I; Gervy C; De Leener A; Englert Y; Costagliola S; Delbaere A
Hum Reprod; 2015 May; 30(5):1196-202. PubMed ID: 25750103
[TBL] [Abstract][Full Text] [Related]
10. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause.
Dólleman M; Depmann M; Eijkemans MJ; Heimensem J; Broer SL; van der Stroom EM; Laven JS; Van Rooij IA; Scheffer GJ; Peeters PH; van der Schouw YT; Lambalk CB; Broekmans FJ
Hum Reprod; 2014 Mar; 29(3):584-91. PubMed ID: 24435779
[TBL] [Abstract][Full Text] [Related]
11. Improving Prediction of Age at Menopause Using Multiple Anti-Müllerian Hormone Measurements: the Tehran Lipid-Glucose Study.
Ramezani Tehrani F; Bidhendi Yarandi R; Solaymani-Dodaran M; Tohidi M; Firouzi F; Azizi F
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32109280
[TBL] [Abstract][Full Text] [Related]
12. The Value of Anti-Müllerian Hormone in the Prediction of Spontaneous Pregnancy: A Systematic Review and Meta-Analysis.
Lin C; Jing M; Zhu W; Tu X; Chen Q; Wang X; Zheng Y; Zhang R
Front Endocrinol (Lausanne); 2021; 12():695157. PubMed ID: 34721287
[TBL] [Abstract][Full Text] [Related]
13. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies.
Jiao X; Meng T; Zhai Y; Zhao L; Luo W; Liu P; Qin Y
Front Endocrinol (Lausanne); 2021; 12():601752. PubMed ID: 33815272
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
Broer SL; Broekmans FJ; Laven JS; Fauser BC
Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
[TBL] [Abstract][Full Text] [Related]
15. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age.
Bentzen JG; Forman JL; Larsen EC; Pinborg A; Johannsen TH; Schmidt L; Friis-Hansen L; Nyboe Andersen A
Hum Reprod; 2013 Jan; 28(1):247-55. PubMed ID: 23136135
[TBL] [Abstract][Full Text] [Related]
16. AMH assessment five or more years after an initially low AMH level.
Desongnis S; Robin G; Dewailly D; Pigny P; Catteau-Jonard S
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():70-74. PubMed ID: 33171420
[TBL] [Abstract][Full Text] [Related]
17. Added value of anti-Müllerian hormone in prediction of menopause: results from a large prospective cohort study.
Dólleman M; Verschuren WM; Eijkemans MJ; Broekmans FJ; van der Schouw YT
Hum Reprod; 2015 Aug; 30(8):1974-81. PubMed ID: 26082477
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
[TBL] [Abstract][Full Text] [Related]
19. Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy.
Fréour T; Barrière P; Masson D
Eur J Cancer; 2017 Mar; 74():1-8. PubMed ID: 28135602
[TBL] [Abstract][Full Text] [Related]
20. The utility of measuring anti-Müllerian hormone in predicting menopause.
Aydogan B; Mirkin S
Climacteric; 2015; 18(6):777-89. PubMed ID: 25845388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]